Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
IDBank at the UBA Regional Conference: From Travel Solutions to Business OpportunitiesJoint statement by the parties consolidatted around the national agenda35% Discount for the 35th Anniversary on Selected IDBank CardsConverse Bank Expands Its International Capabilities Through Cooperation with Citibank N.A.Business loan pre-approval in five minutes — what did Unibank showcase in Gyumri?Converse Bank Expands Its International Capabilities Through Cooperation with Citibank N.A.Bratislava forum to debate Armenia’s strategic future Ucom Service Center in Artashat Reopens at a New Address Ucom and Republican Union of Employers of Armenia Sign Cooperation MemorandumCreate your Visa Digital from Unibank for purchases and transfers Ucom – Main Sponsor of the 21st International Microelectronics Olympiad IDBank and Idram Hold Financial Literacy Session for Young Chess PlayersUcom Supports Silicon Mountains 2026, Driving Innovation and Technological Development IDBank has issued perpetual coupon bonds for the first timeIDBank Supports the Reconstruction of the Spandaryan Canal: Commemorative Plaque Dedicated to the Project SignedIDBank and Idram Presented Several Environmental Initiatives at COP17Ucom Shares Its Experience in Private Sector Engagement in Nature Conservation at COP17 Blue Zone«Here’s the screenshot, the money has been transferred»: IDBank warns of fake payment scamsFirst Steps in Your Career with IDBank: 16th Cycle of IDream LaunchedDigital Architecture for a Sustainable Future: IDBank's Article in Regional Post Magazine
All Timeline »
Life

Multiple sclerosis drug shows promising efficacy

The multiple sclerosis drug is showing promising efficacy in fighting relapses and reducing fatigue.

Back in March 2001, the US Food and Drug Administration approved a drug called ponosimod for use in adult patients with various types of multiple sclerosis. Only now there are research data that show that some drug reduces the number of relapses of the disease and can reduce fatigue - one of the characteristic symptoms of multiple sclerosis.

The respected scientific journal JAMA Neurology has found that ponesimod is more effective in fighting fatigue in multiple sclerosis than another commonly used drug called teriflunomide. It is superior to teriflunomide in reducing relapse rates and reducing the risk of new or existing lesions of myelin found on magnetic resonance imaging.

As reported by everydayhealth.com, ponesimod is used for various types of multiple sclerosis, including the most common relapsing remitting disease and active secondary progressive, which is the most severe. It is not accompanied by remissions and steadily leads to the disability of patients. It is people with this form of multiple sclerosis who show the appearance of new lesions of the myelin layer on MRI scans. Ponesimod must be taken once a day, treatment begins with a period of 14 days, then the doses are increased.